Home / Health / Kerala Backs Generic SMA Drug for Patients
Kerala Backs Generic SMA Drug for Patients
25 Oct
Summary
- KSSP supports Kerala Health Department's generic drug decision.
- Generic Risdiplam aims to improve life quality for SMA patients.
- Natco Pharma key in making affordable cancer treatments accessible.
The Kerala Sastra Sahitya Parishad (KSSP) has publicly supported the Kerala Health Department's decision to distribute a generic version of the drug Risdiplam. This medication is intended for patients diagnosed with Spinal Muscular Atrophy (SMA), a severe genetic disorder characterized by progressive muscle weakness.
The KSSP's endorsement aligns with public health experts who have also backed the government's stance. The organization highlighted that access to such medication is vital for improving the health outcomes and longevity of SMA patients.
KSSP representatives emphasized that the move is a humanitarian effort to broaden access to essential, life-saving treatments for more SMA patients. They pointed to the role of Indian pharmaceutical companies like Natco Pharma in making critical medications more affordable and accessible.
